Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 13/05/2022, Revision: 4, Status: Authorised
TO: